Daily preventive zinc supplementation increases the antibody response against pathogenic Escherichia coli in children with zinc insufficiency: a randomised controlled trial

Abstract Zinc deficiency impairs the antibody-mediated immune response and is common in children from lower-income countries. This study aimed to investigate the impact of different zinc supplementation regimens (7, 10 or 20 mg/day elemental zinc)—therapeutic dispersible zinc tablets (TZ), daily mul...

Full description

Bibliographic Details
Main Authors: Chidchamai Kewcharoenwong, Myint Myint Sein, Arnone Nithichanon, Aranya Khongmee, K Ryan Wessells, Guy-Marino Hinnouho, Maxwell A. Barffour, Sengchanh Kounnavong, Sonja Y. Hess, Charles B. Stephensen, Ganjana Lertmemongkolchai
Format: Article
Language:English
Published: Nature Portfolio 2022-09-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-20445-8
_version_ 1797998311145209856
author Chidchamai Kewcharoenwong
Myint Myint Sein
Arnone Nithichanon
Aranya Khongmee
K Ryan Wessells
Guy-Marino Hinnouho
Maxwell A. Barffour
Sengchanh Kounnavong
Sonja Y. Hess
Charles B. Stephensen
Ganjana Lertmemongkolchai
author_facet Chidchamai Kewcharoenwong
Myint Myint Sein
Arnone Nithichanon
Aranya Khongmee
K Ryan Wessells
Guy-Marino Hinnouho
Maxwell A. Barffour
Sengchanh Kounnavong
Sonja Y. Hess
Charles B. Stephensen
Ganjana Lertmemongkolchai
author_sort Chidchamai Kewcharoenwong
collection DOAJ
description Abstract Zinc deficiency impairs the antibody-mediated immune response and is common in children from lower-income countries. This study aimed to investigate the impact of different zinc supplementation regimens (7, 10 or 20 mg/day elemental zinc)—therapeutic dispersible zinc tablets (TZ), daily multiple micronutrient powder (MNP), daily preventive zinc tablets (PZ) and placebo powder (control)—and compare between baseline and endline antibody production against pathogenic Escherichia coli in Laotian children (aged 6–23 months). Fifty representative plasma samples of each treatment group were randomly selected from 512 children to determine anti-E. coli IgG antibody levels and avidity. Of the 200 children, 78.5% had zinc deficiency (plasma zinc concentration < 65 µg/dL) and 40% had anaemia before receiving zinc supplementation. aAfter receiving the TZ, MNP or PZ regimen, the plasma anti-E. coli IgG levels were significantly increased compared with baseline; the effect on the antibody level was more pronounced in children with zinc deficiency. Interestingly, there was increased anti-E. coli IgG avidity in the control and PZ groups. This study suggests that PZ might be the optimal zinc supplementation regimen to increase both the quantity and quality of antibody responses in children with zinc deficiency. Clinical trial registration: https://clinicaltrials.gov/ct2/show/NCT02428647 (NCT02428647, 29/04/2015).
first_indexed 2024-04-11T10:46:41Z
format Article
id doaj.art-5358286860e94ce9884e97e791bca949
institution Directory Open Access Journal
issn 2045-2322
language English
last_indexed 2024-04-11T10:46:41Z
publishDate 2022-09-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj.art-5358286860e94ce9884e97e791bca9492022-12-22T04:29:01ZengNature PortfolioScientific Reports2045-23222022-09-011211910.1038/s41598-022-20445-8Daily preventive zinc supplementation increases the antibody response against pathogenic Escherichia coli in children with zinc insufficiency: a randomised controlled trialChidchamai Kewcharoenwong0Myint Myint Sein1Arnone Nithichanon2Aranya Khongmee3K Ryan Wessells4Guy-Marino Hinnouho5Maxwell A. Barffour6Sengchanh Kounnavong7Sonja Y. Hess8Charles B. Stephensen9Ganjana Lertmemongkolchai10Faculty of Associated Medical Sciences, Chiang Mai UniversityThe Centre for Research & Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen UniversityDepartment of Microbiology, Faculty of Medicine, Research and Diagnostic Center for Emerging Infectious Diseases (RCEID), Khon Kaen UniversityThe Centre for Research & Development of Medical Diagnostic Laboratories, Faculty of Associated Medical Sciences, Khon Kaen UniversityDepartment of Nutrition, Institute for Global Nutrition, University of CaliforniaDepartment of Nutrition, Institute for Global Nutrition, University of CaliforniaDepartment of Nutrition, Institute for Global Nutrition, University of CaliforniaLao Tropical and Public Health InstituteDepartment of Nutrition, Institute for Global Nutrition, University of CaliforniaDepartment of Nutrition, Institute for Global Nutrition, University of CaliforniaFaculty of Associated Medical Sciences, Chiang Mai UniversityAbstract Zinc deficiency impairs the antibody-mediated immune response and is common in children from lower-income countries. This study aimed to investigate the impact of different zinc supplementation regimens (7, 10 or 20 mg/day elemental zinc)—therapeutic dispersible zinc tablets (TZ), daily multiple micronutrient powder (MNP), daily preventive zinc tablets (PZ) and placebo powder (control)—and compare between baseline and endline antibody production against pathogenic Escherichia coli in Laotian children (aged 6–23 months). Fifty representative plasma samples of each treatment group were randomly selected from 512 children to determine anti-E. coli IgG antibody levels and avidity. Of the 200 children, 78.5% had zinc deficiency (plasma zinc concentration < 65 µg/dL) and 40% had anaemia before receiving zinc supplementation. aAfter receiving the TZ, MNP or PZ regimen, the plasma anti-E. coli IgG levels were significantly increased compared with baseline; the effect on the antibody level was more pronounced in children with zinc deficiency. Interestingly, there was increased anti-E. coli IgG avidity in the control and PZ groups. This study suggests that PZ might be the optimal zinc supplementation regimen to increase both the quantity and quality of antibody responses in children with zinc deficiency. Clinical trial registration: https://clinicaltrials.gov/ct2/show/NCT02428647 (NCT02428647, 29/04/2015).https://doi.org/10.1038/s41598-022-20445-8
spellingShingle Chidchamai Kewcharoenwong
Myint Myint Sein
Arnone Nithichanon
Aranya Khongmee
K Ryan Wessells
Guy-Marino Hinnouho
Maxwell A. Barffour
Sengchanh Kounnavong
Sonja Y. Hess
Charles B. Stephensen
Ganjana Lertmemongkolchai
Daily preventive zinc supplementation increases the antibody response against pathogenic Escherichia coli in children with zinc insufficiency: a randomised controlled trial
Scientific Reports
title Daily preventive zinc supplementation increases the antibody response against pathogenic Escherichia coli in children with zinc insufficiency: a randomised controlled trial
title_full Daily preventive zinc supplementation increases the antibody response against pathogenic Escherichia coli in children with zinc insufficiency: a randomised controlled trial
title_fullStr Daily preventive zinc supplementation increases the antibody response against pathogenic Escherichia coli in children with zinc insufficiency: a randomised controlled trial
title_full_unstemmed Daily preventive zinc supplementation increases the antibody response against pathogenic Escherichia coli in children with zinc insufficiency: a randomised controlled trial
title_short Daily preventive zinc supplementation increases the antibody response against pathogenic Escherichia coli in children with zinc insufficiency: a randomised controlled trial
title_sort daily preventive zinc supplementation increases the antibody response against pathogenic escherichia coli in children with zinc insufficiency a randomised controlled trial
url https://doi.org/10.1038/s41598-022-20445-8
work_keys_str_mv AT chidchamaikewcharoenwong dailypreventivezincsupplementationincreasestheantibodyresponseagainstpathogenicescherichiacoliinchildrenwithzincinsufficiencyarandomisedcontrolledtrial
AT myintmyintsein dailypreventivezincsupplementationincreasestheantibodyresponseagainstpathogenicescherichiacoliinchildrenwithzincinsufficiencyarandomisedcontrolledtrial
AT arnonenithichanon dailypreventivezincsupplementationincreasestheantibodyresponseagainstpathogenicescherichiacoliinchildrenwithzincinsufficiencyarandomisedcontrolledtrial
AT aranyakhongmee dailypreventivezincsupplementationincreasestheantibodyresponseagainstpathogenicescherichiacoliinchildrenwithzincinsufficiencyarandomisedcontrolledtrial
AT kryanwessells dailypreventivezincsupplementationincreasestheantibodyresponseagainstpathogenicescherichiacoliinchildrenwithzincinsufficiencyarandomisedcontrolledtrial
AT guymarinohinnouho dailypreventivezincsupplementationincreasestheantibodyresponseagainstpathogenicescherichiacoliinchildrenwithzincinsufficiencyarandomisedcontrolledtrial
AT maxwellabarffour dailypreventivezincsupplementationincreasestheantibodyresponseagainstpathogenicescherichiacoliinchildrenwithzincinsufficiencyarandomisedcontrolledtrial
AT sengchanhkounnavong dailypreventivezincsupplementationincreasestheantibodyresponseagainstpathogenicescherichiacoliinchildrenwithzincinsufficiencyarandomisedcontrolledtrial
AT sonjayhess dailypreventivezincsupplementationincreasestheantibodyresponseagainstpathogenicescherichiacoliinchildrenwithzincinsufficiencyarandomisedcontrolledtrial
AT charlesbstephensen dailypreventivezincsupplementationincreasestheantibodyresponseagainstpathogenicescherichiacoliinchildrenwithzincinsufficiencyarandomisedcontrolledtrial
AT ganjanalertmemongkolchai dailypreventivezincsupplementationincreasestheantibodyresponseagainstpathogenicescherichiacoliinchildrenwithzincinsufficiencyarandomisedcontrolledtrial